GGrantIndex
Sort

40,608 grants matching prostate cancer

Ascorbate-based biomarkers for predicting radiation response in prostate cancer

$485,743
David M Wilson · University Of California, San Francisco · R01 · FY2016 · CA

Evaluation of Immune-based Combinations in Prostate Cancer

$485,739
Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

TEMPERATURE-SENSITIVE POLYMER MAGNETIC NANOPARTICLES TO TREAT PROSTATE CANCER

$485,631
University Of Texas At Arlington · · FY2009 · Department of Defense

Identification of Novel Pathways Causing NF1-Driven Schwann Cell Tumors

$485,617
Nancy Ratner · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · NS

CNS sirtuins in radiation-induced vascular permeability and neurodegeneration

$485,579
Deedee Smart · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

TARGETED DELIVERY OF NANOPARTICLE-ENCAPSULATED P110BETA-SPECIFIC INHIBITOR FOR PROSTATE CANCER INTERVENTION

$485,437
University Of Kansas Medical Center Research Institute, Inc. · · FY2009 · Department of the Army

A NESTED CASE-CONTROL STUDY OF PROSTATE CARCINOGENESIS

$485,378
Benjamin A. Rybicki · Henry Ford Health System · R01 · FY2015 · ES

METABOLIC REPROGRAMMING OF PROSTATE CANCER AND ANTITUMOR IMMUNITY BY TARGETING LDH-A

$485,366
Beth Israel Deaconess Medical Center, Inc. · · FY2015 · Department of the Army

Investigating the impact of chromosomal instability on prostate cancer aggressiveness

$485,354
Veronica Rodriguez-Bravo · Mayo Clinic Rochester · R01 · FY2024 · CA

Investigating the impact of chromosomal instability on prostate cancer aggressiveness

$485,354
Veronica Rodriguez-Bravo · Mayo Clinic Rochester · R01 · FY2025 · CA

G3BP1 Suppresses SPOP Ubiquitin Ligase to Promote Prostate Tumorigenesis

$485,348
Pengbo Zhou · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA

Alpha-Adrenoceptors in Vascular Wall Growth

$485,314
James E Faber · Univ Of North Carolina Chapel Hill · R01 · FY2010 · HL

COP1 REGULATION OF AR SIGNALING AND PROSTATE CANCER GROWTH AND THERAPY RESISTANCE

$485,310
Feng Yang · Baylor College Of Medicine · R01 · FY2025 · CA

COP1 REGULATION OF AR SIGNALING AND PROSTATE CANCER GROWTH AND THERAPY RESISTANCE

$485,310
Feng Yang · Baylor College Of Medicine · R01 · FY2023 · CA

Volumetric Perfusion MRI of Liver Tumors to Detect Early Response to Chemotherapy

$485,299
Scott B. Reeder · University Of Wisconsin-Madison · RC1 · FY2010 · EB

Dissecting and Predicting Lethal Prostate Cancer using Biologically Informed Artificial Intelligence

$485,271
Eliezer M Van Allen · Dana-Farber Cancer Inst · P50 · FY2023 · CA

Association Analysis Software for Mining Clinical Next-Gen Sequencing Data

$485,252
Timothy J Durfee · Dnastar, Inc. · R44 · FY2013 · HG

Targeting Autophagy in Hereditary Breast Cancer

$485,161
Bing Xia · Rbhs -Cancer Institute Of New Jersey · R01 · FY2015 · CA

Enhancing the efficacy of androgen signaling inhibitors in prostate cancer

$485,160
Xiaoqi Liu · University Of Kentucky · R01 · FY2022 · CA

Enhancing the efficacy of androgen signaling inhibitors in prostate cancer

$485,160
Xiaoqi Liu · University Of Kentucky · R01 · FY2023 · CA

Serum Antibody Profiling with a Carbohydrate Microarray

$485,145
Jeffrey Gildersleeve · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

CLINICAL TRIAL: THE SELENIUM AND VITAMIN E CHEMOPREVENTION TRIAL (SELECT)

$485,142
Rowan A Chlebowski · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · M01 · FY2009 · RR

Nitric Oxide as a Modifier of Oxidative Stress

$485,131
David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA

Aspirin/Folate Prevention of Large Bowel Polyps

$485,122
John Anthony Baron · Univ Of North Carolina Chapel Hill · R01 · FY2013 · CA

Charles Drew University/UCLA Cancer Center Partnership to Eliminate Cancer Health

$485,113
Robin Farias-Eisner · University Of California Los Angeles · U54 · FY2012 · CA